Trials / Completed
CompletedNCT01245738
Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)
Dyslipidemia: REsidual and Mixed Abnormalities IN Spite of Statin Therapy: The Dyslipidemia REMAINS Study: A Multicenter, Prospective, Observational Study of Lipid Profiles and Treatment Patterns at Presentation and After 12 Weeks of Statin Therapy Among Indian Adults Presenting With First Coronary Event
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 635 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
The current study is proposed to investigate the pattern of dyslipidemia and of lipid treatment practices in patients in India experiencing their first acute cardiovascular event and the extent of residual dyslipidemia after 12 weeks of treatment with statins. Dyslipidemia definitions are per the National Cholesterol Education Program - Adult Treatment Panel III (NCEP-ATP III).
Conditions
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2010-11-22
- Last updated
- 2017-03-10
- Results posted
- 2014-08-22
Source: ClinicalTrials.gov record NCT01245738. Inclusion in this directory is not an endorsement.